Verrica Pharmaceuticals, Inc. (VRCA)
4.11
-0.07
(-1.67%)
USD |
NASDAQ |
Oct 09, 16:00
4.10
-0.01
(-0.24%)
After-Hours: 20:00
Verrica Pharmaceuticals Total Assets (Quarterly) : 36.02M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.02M |
| March 31, 2026 | 38.79M |
| December 31, 2025 | 47.52M |
| September 30, 2025 | 40.90M |
| June 30, 2025 | 39.11M |
| March 31, 2025 | 42.18M |
| December 31, 2024 | 54.62M |
| September 30, 2024 | 32.93M |
| June 30, 2024 | 52.01M |
| March 31, 2024 | 66.31M |
| December 31, 2023 | 81.60M |
| September 30, 2023 | 97.15M |
| June 30, 2023 | 62.20M |
| March 31, 2023 | 68.64M |
| December 31, 2022 | 44.72M |
| September 30, 2022 | 49.15M |
| June 30, 2022 | 63.44M |
| March 31, 2022 | 71.62M |
| Date | Value |
|---|---|
| December 31, 2021 | 80.12M |
| September 30, 2021 | 88.76M |
| June 30, 2021 | 99.03M |
| March 31, 2021 | 108.10M |
| December 31, 2020 | 74.15M |
| September 30, 2020 | 80.38M |
| June 30, 2020 | 87.24M |
| March 31, 2020 | 94.44M |
| December 31, 2019 | 68.83M |
| September 30, 2019 | 76.07M |
| June 30, 2019 | 81.25M |
| March 31, 2019 | 85.98M |
| December 31, 2018 | 91.91M |
| September 30, 2018 | 98.80M |
| June 30, 2018 | 104.72M |
| March 31, 2018 | 29.40M |
| December 31, 2017 | 9.083M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 31.71M |
| Shareholders Equity (Quarterly) | 4.307M |
| Debt to Equity Ratio | 0.4202 |
| Current Ratio | 1.333 |
| Net Debt Paydown Yield | 7.73% |